Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Changan Granules
- Development stage
- Unknown
- Lead developer
- Shanghai Traditional Chinese Med Dayuanchuang Tech
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Changan Granules is a Traditional Chinese Medicine (TCM) formulation developed by Shanghai Traditional Chinese Medicine University Yuanchuang Technology Co., Ltd. specifically for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D). The formula is derived from the classical TCM prescription "Tongxie Yaofang," which has been modified to better address the pathophysiology of IBS-D, including abdominal pain and frequent loose stools. Its mechanism of action is multi-targeted, involving the reduction of visceral hypersensitivity, modulation of the brain-gut axis, and regulation of intestinal permeability and gut microbiota. Clinical studies have indicated that Changan Granules can significantly improve the IBS-D Symptom Severity Score (IBS-SSS) and patient quality of life by inhibiting mast cell activation and regulating serotonin (5-HT) levels in the colonic mucosa.
- Brand names
- Changan Granules
- Other names
- Changan KeliChang-An-Ke-LiChang'an Granule
02
Targets
5-HT (Serotonin receptors)
Beyond the preview
Go deeper on Changan Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Changan Granules.